Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2008 3
2009 3
2010 1
2011 4
2012 4
2013 12
2014 3
2015 6
2016 1
2017 4
2018 5
2019 3
2020 7
2021 4
2022 12
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Anti-inflammatory-antioxidant modifications and synbiotics improved health-related conditions in patients with progressive forms of multiple sclerosis: A single-center, randomized clinical trial.
Moravejolahkami AR, Chitsaz A, Hassanzadeh A, Paknahad Z. Moravejolahkami AR, et al. Among authors: chitsaz a. Complement Ther Clin Pract. 2023 Nov;53:101794. doi: 10.1016/j.ctcp.2023.101794. Epub 2023 Aug 17. Complement Ther Clin Pract. 2023. PMID: 37651846 Clinical Trial.
Third COVID-19 vaccine dose for people with multiple sclerosis who did not seroconvert following two doses of BBIBP-CorV (Sinopharm) inactivated vaccine: A pilot study on safety and immunogenicity.
Sedaghat N, Etemadifar M, Lotfi N, Sayahi F, Chitsaz A, Salari M, Ghasemi Movaghar A. Sedaghat N, et al. Among authors: chitsaz a. Front Immunol. 2023 Feb 21;14:952911. doi: 10.3389/fimmu.2023.952911. eCollection 2023. Front Immunol. 2023. PMID: 36895555 Free PMC article.
Effects of anti-Inflammatory-antioxidant-rich diet and co-supplemented synbiotics intervention in patients with progressive forms of multiple sclerosis: a single-center, single-blind randomized clinical trial.
Moravejolahkami AR, Chitsaz A, Hassanzadeh A, Paknahad Z. Moravejolahkami AR, et al. Among authors: chitsaz a. Nutr Neurosci. 2023 Nov;26(11):1078-1089. doi: 10.1080/1028415X.2022.2128010. Epub 2022 Sep 29. Nutr Neurosci. 2023. PMID: 36173031 Clinical Trial.
72 results